In a Columbia University School of Nursing study surveying 1,185 U.S.-based adults about AI use in secure medical portals, 63% of patients said they would not endorse AI-generated… read more.
Someone shopping for an over-the-counter (OTC) hearing aid may have to sort through dozens of products, determine which ones are regulated by the FDA, figure out what insurance… read more.
Novartis announced that the European Commission (EC) has approved Cosentyx (secukinumab) for the treatment of adults with polymyalgia rheumatica (PMR) who have had an inadequate response to glucocorticoids or… read more.
Eli Lilly and Company announced positive late-breaking one-year results from the Phase 3 SHINE-2 study of Omvoh (mirikizumab-mrkz) in pediatric patients ages 6 to 17 with moderately to… read more.
States in the U.S. that legalized online sports betting saw increases in the use of depression and anxiety medications as well as outpatient diagnoses for depression and anxiety,… read more.
New Australian research reveals that teenagers, their families and GPs are placed under increased pressure due to long waits for specialist mental healthcare, as researchers call on GPs… read more.
The rapid expansion of private testosterone prescribing risks extending treatment beyond men with clearly defined need to people with non-specific symptoms and borderline test results, for whom the… read more.
UCB announced that the FDA has approved the first self-administered once-daily, autoinjector administration option for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine… read more.
Permitting medical device manufacturers to submit bulk summary reports of adverse events to the US Food and Drug Administration (FDA), rather than reporting individual cases, often fails to… read more.
Abbott announced FDA approval for updates to the CardioMEMS HF System that enable new patient-facing capabilities through the CardioGuide HF App. For the first time, care teams can… read more.
Insulin efsitora alfa can be used, within its marketing authorisation, as an option to treat type 2 diabetes in adults. Use the least expensive option of the suitable… read more.
AnaptysBio, Inc. a company focused on managing the financial collaborations for Jemperli with Tesaro, a GSK company, and Quimilza (imsidolimab) with Vanda, announced that GSK has received U.S…. read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
